2023 Impact Factor
The quest for effective anti-aging treatments has driven scientific and medical research, particularly pharmacological approaches. In the aging model organism
As major components of the ECM, collagen proteins have significant potential as therapeutic targets for anti-aging interventions. This study aimed to contribute to the development of innovative anti-aging treatments by harnessing the regenerative capabilities of essential collagen proteins. By investigating the role of collagen proteins in the lifespan and health span of
We collected transcriptomic data on
We used DNA encoding full-length (aa 1-2944) recombinant hCOL7A1, the chain region (17-2,944 aa), the non-helical region (17-1,253 aa), and the triple-helical region (1,254-2,784 aa). These DNA fragments were amplified using Pfu DNA polymerase. The amplified DNAs were inserted into pcDNA3.1-HA or pET-28a vectors. Recombinant proteins were overexpressed in
Ultra-high performance LC-MS analysis of the trypsin digestion products was performed using a TripleTOF 5600+ instrument (ABSCIEX, Framingham, MA, USA) coupled with a 1290 Infinity II system (Agilent, Santa Clara, CA, USA). Acquisition was performed on a quadrupole time-of-flight mass spectrometer over a full scan range of m/z 50-3,000. The resulting data were searched against COL7A1 protein (bonding collagen T7) using BPVflex software (ABSCIEX) and PeakView® software (ABSCIEX). For the BPVflex search, the total intensity threshold was set at 0.05% of the intensity of the base chromatogram peak.
Lifespan assays were carried out at 20°C on liquid culture plates using standard protocols and were replicated in three independent experiments.
On day 10, 10-15, worms were transferred to fresh NGM plates and recorded for 30 s using a microscope (Olympus SZ61 microscope with Olympus camera eXcope T300; Olympus, Tokyo, Japan). Subsequently, five independent movement clips per experimental condition were analyzed using TSView 7 software (ver. 7.1) (Olympus, Tokyo, Japan), and the average speed was calculated as the distance traveled (mm) per second. The body-bending frequency of 30 worms per condition was assessed for 20 s using an SZ61 microscope (Olympus). Body-bend counts were recorded using an Olympus eXcope T300 camera at an 18-fold optical zoom. The videos were played back at a speed of 0.5× and counted. A count was recorded each time the back of the nematode pharynx reached its maximum bend in the opposite direction of the previous count.
For the fertility assay, worms were synchronized, and a single L4 nematode was transferred onto a single plate by applying vehicle or collagen solutions, and then transferred to fresh plates. The progeny of the worms were allowed to hatch and were counted.
Synchronized worms were treated under each condition for 10 days. For the oxidative stress assay, 30 worms were placed on solid NGM plates containing 0.4M paraquat (PESTANAL; Sigma-Aldrich) for 3 h. The assays were repeated nine times, and the paraquat plates were freshly prepared on the day of the assay. For the thermotolerance assay, 30 worms were exposed to 35°C for 16 h and surviving worms were counted. Assays were performed in triplicate, and the survival rate was estimated.
To assess antioxidant enzyme activity, 10-day-old worms were ground in liquid nitrogen. Superoxide dismutase (SOD) and catalase activity levels were measured using an SOD colorimetric activity kit (Invitrogen, Carlsbad, CA, USA) and a catalase activity colorimetric/fluorometric assay kit (Biovision, Milpitas, CA, USA), respectively. Worm pellet samples were assessed in triplicate according to the manufacturer’s protocol. SOD and catalase activities were determined using standard curves, followed by normalization to protein concentrations using a bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA).
Nematodes were synchronized and treated for 10 days with vehicle or collagen solutions from the L4 larval stage (day 0). To measure lipofuscin accumulation, day 10 worms were washed three times with M9 buffer and distributed in a 96-well plate (Porvair Sciences, Norfolk, UK; black with glass-bottomed imaging plates, #324002). Lipofuscin autofluorescence was determined using a fluorescence plate reader (Synergy H1, Agilent Technology, Winooski, VT, USA; excitation: 390-410, emission: 460-480) and normalized to the stable signal of the worms (excitation: 280-300, emission: 320-340) as a blank.
TG content was measured using a triglyceride colorimetric assay kit (Abcam, Waltham, MA, USA) according to the manufacturer’s protocol. Briefly, worm pellets were frozen in liquid nitrogen containing 5% Triton X-100. The pellets were sonicated and diluted for protein determination using a BCA assay (Pierce). The samples were heated to 80°C and shaken for 5 min, then cooled to room temperature to solubilize the TGs. TG content was normalized to protein content, and three independently collected worm pellets were assayed for each experimental condition.
Primary human dermal fibroblasts (HDFs; American Type Culture Collection, Manassas, VA, USA) and immortalized HaCaT cells (Addexbio, San Diego, CA, USA) were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Lonza, Slough, UK) containing 4.5 g/L glucose and supplemented with 2 mM L-glutamine, 100 IU/mL penicillin, 100 μg/mL streptomycin, and 10% (v/v) fetal bovine serum (FBS) (Sigma-Aldrich). The cells were cultivated in T-flasks at 37°C in a humidified atmosphere containing 5% CO2.
HaCaT cells were seeded in 12-well plates (1×105 cells per well) and grown in DMEM containing 5% FBS for 24 h. The medium was then replaced with fresh assay medium containing 0.1% FBS, and the corresponding treatment was tested for collagen production. After 48 h of incubation, the cell culture medium was collected and centrifuged at 3,000 rpm for 15 min. The levels of collagen I secreted from treated cells were quantified using an enzyme-linked immunosorbent assay kit (Takara Bio Inc., Otsu, Japan) according to the manufacturer’s instructions. Measurements were repeated at least three times with an independent cohort of cells.
HFDs were seeded into six-well plates (3×105 cells per well) and grown in DMEM containing 5% FBS for 24 h. Next, the medium was replaced with fresh assay medium containing 0.1% FBS. After 48 h of incubation, the cell culture medium was completely removed and stored at −80°C. RNA was extracted and assayed using a Bioanalyzer 2100 (Agilent Technologies, Waltham, MA, USA) in combination with an RNA 6000 Nano kit. Matched samples with high RNA integrity scores were subjected to sequencing. For library preparation, 2 mg of total RNA per sample was processed using a TruSeq RNA Sample Prep Kit (Illumina, San Diego, CA, USA) following the manufacturer’s instructions. The quality and quantity of the libraries were determined using an Agilent Bioanalyzer 2100 in combination with FastQC v0.11.7, and sequencing was performed on a HiSeq4000 in the SR/50 bp/high output mode at the Macrogen Bioinformatics Center (Macrogen, Seoul, Korea). The libraries were multiplexed at five units per lane. Sequencing resulted in 35 Mio reads per sample. Sequence data were extracted in FastQ format using bcl2fastq v1.8.4 and used for mapping. FASTQ output files were aligned to WBcel235
All experiments were repeated at least three times, with identical or similar results. Data represent biological replicates. Statistical analysis was performed for each assay. The data satisfied the hypotheses of the statistical tests described in each experiment. Data are expressed as the mean ± standard deviation in all figures unless stated otherwise. R software (ver. 4.1.1) (https://www.r-project.org) was used for statistical analyses. A
Source data for all figures and tables used in this study. Experimental data supporting the plots within this paper and other findings of this study are available from the corresponding author upon reasonable request. The RNA-seq data generated in the present study have been deposited in NCBI’s SRA and are accessible through the submission number PRJNA1143071. The source data are provided in this study.
In this study, we aimed to identify common genetic mediators of
To determine whether the association between collagen proteins and long-lived circumstances observed was consistent with actual longevity, we conducted lifespan studies in a nematode model using human collagen proteins. We selected collagen types I (COL1A1), VII (COL7A1), and XXI (COL21A1) as experimental candidates based on the importance of the ECM for longevity (Teuscher
We performed lifespan assays with COL1A1, COL7A1, and COL21A1 at a dose range of 0-160 ppm and confirmed significant lifespan extension with COL1A1 and COL7A1. In the lifespan assay with COL1A1, a significant increase in the average lifespan was observed (2.2-3.1%, 40 ppm; 5.7-7.5%, 80 ppm; 7.5-9.25%, 160 ppm;
RNA-seq analysis after 160 ppm collagen peptide treatment of HDFs revealed that COL7A1 attenuated cellular metabolic responses and showed a dramatic increase in collagen complex-related gene expression levels compared to COL1A1 and COL21A1 (Fig. 4A). To investigate the effect on collagen synthesis, we determined the amount of type I collagen secreted into the culture media of HaCaT cells stimulated with collagen peptides. In accordance with the altered gene expression levels, COL7A1 induced a 1.7-fold increase in the synthesis of collagen type I compared to COL1A1 and COL21A1 (Fig. 4B). To further explore the molecular mechanisms underlying COL7A1-mediated longevity, we examined the expression of skin-senescence-associated genes. COL7A1 induced the expression of collagen-containing ECM genes and attenuated the expression of genes involved in protein metabolism and phosphorylation (Fig. 4C, 4D). In addition, collagen type I synthesis was increased in a dose-dependent manner by treatment with COL7A1 (Fig. 4E).
Our investigation established collagen as a promising biotarget for longevity, indicating its potential to address the decline in both organismal and skin senescence. This discovery fills a significant gap in accessible therapeutic targets, particularly for interventions where safety and minimal side effects are crucial. Although collagen shows potential as a therapeutic target, its ability to prevent senescence-associated factors during the aging process, before the onset of age-related decline warrants further investigation. This highlights the need for further research to fully understand the capacity of collagen to promote healthy aging.
Collagen, a major component of the ECM, plays a crucial role in maintaining skin integrity and resilience. Structurally, collagens are composed of polypeptide chains that form triple helices, which are the hallmarks of collagen proteins and the components that confer strength and durability (Sorushanova
In this study, COL7A1 extended the lifespan of the aging model organism
This study was supported by Konkuk University in 2024. The analysis of COL7A1 protein was supported by the Gyeonggido Business & Science Accelerator (GBSA).
The authors declare no conflict of interest associated with this manuscript.
Conception and design: Juewon Kim, Woo-Young Seo, Donghyun Cho. Collection and assembly of data: Juewon Kim, Hyeryung Kim, Eunji Lee. Data analysis and interpretation: Juewon Kim, Hyeryung Kim, Eunji Lee, Woo-Young Seo. Manuscript writing: Juewon Kim, Woo-Young Seo. Final approval of the manuscript: All authors. Accountable for all aspects of the work: All authors.